These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 13885426)

  • 1. The implications of extrapyramidal symptoms in the treatment of schizophrenia.
    DENHAM J
    Rev Can Biol; 1961 Jun; 20():545-8. PubMed ID: 13885426
    [No Abstract]   [Full Text] [Related]  

  • 2. The relationsip between the anti-hallucinatory effect and extrapyramidal symptoms induced by fluphenazine. (A study in 40 chronic schizophrenics).
    KRUSE W
    Curr Ther Res Clin Exp; 1961 Jan; 3():19-22. PubMed ID: 13754636
    [No Abstract]   [Full Text] [Related]  

  • 3. Extrapyramidal symptoms of triflupromazine, mepazine, prochlorperazine.
    DARLING HF
    Dis Nerv Syst; 1959 Dec; 20():569-71. PubMed ID: 13814128
    [No Abstract]   [Full Text] [Related]  

  • 4. A parallel between the profile of clinical activity and the character of extrapyramidal activity of neuroleptics.
    CORNMAN HD
    Rev Can Biol; 1961 Jun; 20():575-7. PubMed ID: 13881414
    [No Abstract]   [Full Text] [Related]  

  • 5. Relevance of drug-induced extrapyramidal reactions to behavioral changes during neuroleptic treatment. II. Combined treatment with trifluoperazine-amobarbital.
    BRUNE GG; KOBAYASHI T; BULL C; TOURLENTES TT; HIMWICH HE
    Compr Psychiatry; 1962 Oct; 3():292-6. PubMed ID: 13873984
    [No Abstract]   [Full Text] [Related]  

  • 6. Some comments on the psychodynamic aspects of the extrapyramidal reactions.
    SARWER-FONER GJ
    Rev Can Biol; 1961 Jun; 20():623-9. PubMed ID: 14497302
    [No Abstract]   [Full Text] [Related]  

  • 7. The relationship of drug-induced neurological phenomena on therapeutic outcome.
    FREYHAN FA
    Rev Can Biol; 1961 Jun; 20():579-82. PubMed ID: 13895118
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effect of a new phenothiazine derivative--fluophenazine--on extrapyramidal manifestations of a hyperkinetic type].
    REBUCCI GG
    G Psichiatr Neuropatol; 1962; 90():269-82. PubMed ID: 14490858
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment of drug-induced extrapyramidal symptoms. (A comparative study of three antiparkinson agents).
    KRUSE W
    Dis Nerv Syst; 1960 Feb; 21():79-81. PubMed ID: 14412284
    [No Abstract]   [Full Text] [Related]  

  • 10. Extrapyramidal symptoms associated with the administration of trifluoperazine: report of a case treated with diphenhydramine.
    FANNING WJ
    Can Med Assoc J; 1961 Dec; 85(27):1459. PubMed ID: 13891541
    [No Abstract]   [Full Text] [Related]  

  • 11. Phenothiazine ataraxics. Extrapyramidal reactions.
    CAIN HD; MALCOLM M
    Calif Med; 1960 Jul; 93(1):24-8. PubMed ID: 13806816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relevance of drug-induced extrapyramidal reactions to behavioral changes during neuroleptic treatment. I. Treatment with trifluoperazine singly and in combination with trihexyphenidyl.
    BRUNE GG; MORPURGO C; BIELKUS A; KOBAYASHI T; TOURLENTES TT; HIMWICH HE
    Compr Psychiatry; 1962 Aug; 3():227-34. PubMed ID: 13873985
    [No Abstract]   [Full Text] [Related]  

  • 13. Extrapyramidal modification of fine movements: a "conditio sine qua non" of the fundamental therapeutic action of neuroleptic drugs.
    HAASE HJ
    Rev Can Biol; 1961 Jun; 20():425-49. PubMed ID: 13903363
    [No Abstract]   [Full Text] [Related]  

  • 14. Extrapyramidal side effects of trifluoperazine.
    MOULTON SE; JOHNSON FP; PRICKMAN LE
    Proc Staff Meet Mayo Clin; 1961 May; 36():268-70. PubMed ID: 13773255
    [No Abstract]   [Full Text] [Related]  

  • 15. [CORRECTION BY ETYBENZATROPINE OF EXTRAPYRAMIDAL SYMPTOMS DUE TO NEUROLEPTICS].
    BORENSTEIN P; BLES G
    Presse Med (1893); 1964 May; 72():1595-6. PubMed ID: 14149342
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of mentally retarded with haloperiodole, with special reference to the counteraction of the extrapyramidal symptoms occurring in connection with this treatment.
    KIVALO E; AMNELL G
    Ann Paediatr Fenn; 1961; 7():320-8. PubMed ID: 14456579
    [No Abstract]   [Full Text] [Related]  

  • 17. [Extrapyramidal syndromes induced by chlorpromazine and reserpine].
    BOURGUIGNON A
    Sem Hop Ther Paris; 1960 Jul; 36():632-3. PubMed ID: 13803333
    [No Abstract]   [Full Text] [Related]  

  • 18. [Oxygen in the therapy of extrapyramidal syndromes induced by neuroleptics. Practical and theoretical importance].
    DEMBER HC; FLORIO D
    Ann Med Psychol (Paris); 1962 Apr; 120(1)():759-65. PubMed ID: 13885297
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effects of tranquilizing drugs (reserpine, chlorpromazine) on extrapyramidal motility disorders].
    BRANDER E
    Monatsschr Psychiatr Neurol; 1956; 132(2-3):81-95. PubMed ID: 13369436
    [No Abstract]   [Full Text] [Related]  

  • 20. A HYPOTHESIS CONCERNING A SITE OF ACTION OF TRANQUILIZING DRUGS AND THE SIGNIFICANCE OF ASSOCIATED EXTRAPYRAMIDAL MOTOR PHENOMENA.
    VENNING GR
    J New Drugs; 1963; 3(6):351-5. PubMed ID: 14113558
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.